NKGNNKGN info
$0.48info-2.85%24h
Global rank32591
Market cap$10.44M
Change 7d-39.08%
YTD Performance-82.65%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    (NKGN) Stock Overview

    NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials. The company was founded in 2017 and is based in Santa Ana, California.

    NKGN Stock Information

    Symbol
    NKGN
    Address
    3001 Daimler StreetSanta Ana, CA 92705United States
    Founded
    -
    Trading hours
    -
    Website
    https://nkgenbiotech.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    949-396-6830

    (NKGN) Price Chart

    -
    Value:-

    Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.477
    N/A
    Market Cap
    $10.44M
    N/A
    Shares Outstanding
    21.89M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org